Mirum Pharmaceuticals (MIRM) Payables (2020 - 2025)
Historic Payables for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $12.2 million.
- Mirum Pharmaceuticals' Payables rose 2746.99% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year increase of 2746.99%. This contributed to the annual value of $14.6 million for FY2024, which is 9711.43% up from last year.
- Per Mirum Pharmaceuticals' latest filing, its Payables stood at $12.2 million for Q3 2025, which was up 2746.99% from $17.7 million recorded in Q2 2025.
- Mirum Pharmaceuticals' Payables' 5-year high stood at $17.7 million during Q2 2025, with a 5-year trough of $4.9 million in Q1 2022.
- For the 5-year period, Mirum Pharmaceuticals' Payables averaged around $9.7 million, with its median value being $9.2 million (2021).
- Per our database at Business Quant, Mirum Pharmaceuticals' Payables skyrocketed by 19089.18% in 2021 and then plummeted by 3187.04% in 2024.
- Mirum Pharmaceuticals' Payables (Quarter) stood at $9.2 million in 2021, then decreased by 5.19% to $8.7 million in 2022, then dropped by 14.66% to $7.4 million in 2023, then surged by 97.11% to $14.6 million in 2024, then decreased by 16.77% to $12.2 million in 2025.
- Its last three reported values are $12.2 million in Q3 2025, $17.7 million for Q2 2025, and $11.6 million during Q1 2025.